If youre experiencing any of these symptoms, especially while taking GLP-1 medications, its a good idea to consult your doctor
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
Aim for steady weight loss Slower, medically supervised weight reduction may be less stressful for the hair cycle
This limitation can be addressed through the administration of Exendin-4 via intraperitoneal injection
Thus, Y1R and Y2R appear to have opposite effects on anxiety which can be explained by their receptor localization
Prepared vials should remain refrigerated between 2-8C and protected from repeated temperature changes
